| 產(chǎn)品編號(hào) | bs-16785R-BF350 |
| 英文名稱 | Rabbit Anti-KLRF2/BF350 Conjugated antibody |
| 中文名稱 | BF350標(biāo)記的殺傷細(xì)胞凝集素樣受體F2抗體 |
| 別 名 | Activating coreceptor NKp65; Killer cell lectin-like receptor subfamily F member 2; KLRF2; KLRF2_HUMAN; Lectin-like receptor F2; NKp65. |
| 規(guī)格價(jià)格 | 100ul/2980元 購(gòu)買 大包裝/詢價(jià) |
| 說 明 書 | 100ul |
| 研究領(lǐng)域 | 細(xì)胞生物 免疫學(xué) 自然殺傷細(xì)胞 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Human, |
| 產(chǎn)品應(yīng)用 | ICC=1:50-200 IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 24kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human KLRF2 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲(chǔ) 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 產(chǎn)品介紹 |
background: C-type lectin-like receptor involved in natural killer cell mediated cytotoxicity and cytokine secretion in keratinocytes via its interaction with CLEC2A. Function: C-type lectin-like receptor involved in natural killer cell mediated cytotoxicity and cytokine secretion in keratinocytes via its interaction with CLEC2A. Subunit: Homodimer; non disulfide-linked. Interacts with CLEC2A. Subcellular Location: Cell membrane. Tissue Specificity: Contains 1 C-type lectin domain. Post-translational modifications: N-glycosylated. Similarity: Contains 1 C-type lectin domain. Database links: Entrez Gene: 100431172 Human SwissProt: D3W0D1 Human Unigene: 725113 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
